Drug
Obatoclax
Obatoclax: highest development phase Phase 1, developed by Teva. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Teva
Trials
| Drug | Phase | Indication |
|---|---|---|
| Obatoclax mesylate (GX15-070MS) NCT00438178 | Phase 1 | Hematological Malignancies |
Latest
No recent events.
Follow Obatoclax on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.